Common experiences after the first injection include: Mild soreness or redness at the injection site (usually resolves within 12 days) Slight improvement in energy levels or mood No immediate noticeable change (particularly common if deficiency is severe) Rarely, mild side effects such as headache or dizziness Some patients report their urine becoming brighter or more intensely coloured following injection, which occurs because excess B12 is excreted renally
Some side effects that may be seen after injectable B12 are: mild diarrhea itching or rash nausea and vomit headache swelling venous thrombosis pulmonary edema or congestive heart failure allergic reaction or anaphylaxis (rare) Caution : Vitamin B12 in the form of cyanocobalamin (found in most dietary supplements) should be avoided by people with Lebers disease (hereditary optic neuropathy), as it can cause severe atrophy of the optic nerve (10)
Unlike metabolic compoundssuch as those compared in our Retatrutide vs Tirzepatide or MOTS-c vs 5-Amino-1MQ guideswhich focus on fat loss and cellular energy, BPC-157 and TB-500 are strictly tissue-healing agents
MOTS-C 10mg Summary Description: MOTS-c (Mitochondrial ORF of the 12S rRNA type c) is a mitochondrial-derived peptide that plays a vital role in regulating metabolism, energy balance, and cellular stress responses
However, this represents an off-label use without established protocols or evidence base
The prevailing theory on why Vitamin B12 may be effective in many neuromuscular and other conditions is that the METHYL (methylcobalamin) group acts to aid in detoxification and to improve cellular energy
